glp-1 hidradenitis suppurativa The therapeutic mechanism of GLP-1RAs in the treatment of HS Glucagon‐Like Peptide‐1 Receptor Agonists as

Contrave came first in 2014

S.ChengX

Preparation and therapeutic evaluation of engineered semaglutide and statin-lipid conjugate-based nanoparticle

Mazdutide demonstrates improvements in blood lipids, blood pressure, uric acid levels, liver enzymes, and liver fat content

Ganju and colleagues concluded, These results provide the first large-scale evidence supporting GLP-1RAs as a safe and potentially beneficial adjunct in Crohns disease management. They went on to note that prospective studies and guideline development are urgently needed to define their role in integrated IBD and metabolic care.

In the retatrutide trials, the ratio of fat loss to lean loss was favorable compared to caloric restriction alone, where lean mass can represent 25-35% of total weight lost